Suven to take part in pharma meet

Hyderabad | Updated on January 13, 2011 Published on January 13, 2011

Suven Life Sciences, a Hyderabad-based bio-pharmaceutical company, has announced it is taking part in the JP Morgan Healthcare Conference 2011 being hosted at San Francisco, US, during January 10-13 and explore option to raise fund and partner with other companies. Mr Venkat Jasti, Chief Executive Officer of Suven, in a statement said that the company will discuss plans for fund raising and potential tie-ups for its phase-2 ready clinical candidate for cognition in Alzheimer's and Schizophrenia. The company has 12 internally discovered therapeutic drug candidates currently in pre-clinical stage of development targeting conditions such as dementia, depression and obesity among others, according to a company statement.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on January 13, 2011
This article is closed for comments.
Please Email the Editor